Aradigm to Present at BIO CEO & Investor Conference 2008 on February 13

Aradigm Corporation (OTCBB:ARDM) today announced that its President and Chief Executive Officer Igor Gonda, Ph.D. will present at the BIO CEO & Investor Conference 2008 on Wednesday, February 13 at 12:30 p.m. Eastern Time (9:30 a.m. Pacific time). The conference is being held at the Waldorf-Astoria Hotel in New York City.

Interested parties can access a live audio webcast and slide presentation at www.aradigm.com. An archived presentation will be available on the Web site for 14 days.

About Aradigm

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment and prevention of severe respiratory diseases by pulmonologists. Current activities include partnered and self-initiated development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary hypertension, inhalation anthrax infections and smoking cessation. More information about Aradigm can be found at www.aradigm.com.

Aradigm is a registered trademark and the Aradigm Logo is a trademark of Aradigm Corporation.

SOURCE: Aradigm